Journal Publishes Pivotal Data Demonstrating Efficacy and Safety of ELOCTATE for Hemophilia A

By: Benzinga
Today Biogen Idec (NASDAQ: BIIB ) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) announced that the detailed phase 3 data for the companies' investigational long-lasting
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.